Sangmi Kim
- Aging top 5%
- Biological Psychiatry top 10%
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 3
- Oncology top 10%
- Cancer Risks and Factors 4
- Colorectal Cancer Treatments and Studies 3
- Physiology top 10%
- Telomeres, Telomerase, and Senescence 4
-
- Inflammatory mediators and NSAID effects 5
- Antibiotics Pharmacokinetics and Efficacy 3
-
- Lung Cancer Treatments and Mutations 5
-
- Estrogen and related hormone effects 3
- Co-authors
- Dale P. SandlerJack A. TaylorRobert S. SandlerChristine G. ParksJessie A. SatiaSusan HalabiJoseph A. GalankoJohn T. Woosley
- Partner nations
- United StatesSouth KoreaUnited Kingdom
In The Last Decade
Sangmi Kim
51 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 123
- Aging 57
- Biological Psychiatry 36
- Cancer Research 186
- Oncology 337
- Physiology 255
Countries citing papers authored by Sangmi Kim
This map shows the geographic impact of Sangmi Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sangmi Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sangmi Kim more than expected).
Fields of papers citing papers by Sangmi Kim
This network shows the impact of papers produced by Sangmi Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sangmi Kim. The network helps show where Sangmi Kim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sangmi Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 2 | |
| 12 | 2021 | 17 | |
| 13 | 2021 | 4 | |
| 14 | 2021 | 6 | |
| 15 | 2021 | 7 | |
| 16 | 2017 | 64 | |
| 17 | 2016 | 14 | |
| 18 | 2013 | 38 | |
| 19 | Birth outcomes of late pregnant women and suggestions for policy support | 2012 | 2 |
| 20 | 2009 | 155 |
About Sangmi Kim
Sangmi Kim is a scholar working on Oncology, Aging and Cancer Research, having authored 61 papers that have together received 1.2k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (5 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Risks and Factors (4 papers), Telomeres, Telomerase, and Senescence (4 papers), Cancer Genomics and Diagnostics (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Estrogen and related hormone effects (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). The work is most often cited by research in Aging (57 citations), Biological Psychiatry (36 citations) and Cancer Research (186 citations). Sangmi Kim has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include Dale P. Sandler, Jack A. Taylor, Robert S. Sandler, Christine G. Parks, Jessie A. Satia, Susan Halabi, Joseph A. Galanko, John T. Woosley, Jane C. Schroeder and Christopher F. Martin. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.